Brain-Computer Interfaces

Brain-computer interfaces (BCIs) read neural activity and translate it into signals a machine can use — and, in some designs, write information back. They range from non-invasive headsets to fully implanted electrode arrays. After decades as a laboratory science, implanted BCIs have entered early human trials.

For people with paralysis or loss of speech, a working BCI is a restored channel to the world. Beyond medicine, BCIs raise the most direct questions yet about the boundary between mind and machine — and about who owns the data that crosses it.

Several companies and academic groups have implanted devices in small numbers of human participants under investigational approvals. Participants control cursors, type and operate devices by intention. Systems remain slow, require calibration, and face open questions about durability. Non-invasive systems are far less capable but far more accessible.

Academic BCI consortia

Decades of foundational work on decoding motor intention.

Implant companies

Building high-channel-count devices and pursuing regulatory approval.

Regulators

Approve investigational trials and will define the path to routine clinical use.

Patient advocates and ethicists

Consent, device abandonment, neural data rights.

1. 2004–2006

   First human trials of intracortical arrays

   Cursor control by a participant with tetraplegia.

2. 2010s

   Higher-bandwidth decoding

   Typing and robotic-arm control demonstrated.

3. 2023

   First-in-human approvals for new implant designs

   Company-led trials begin.

4. 2024–2026

   Participants use devices at home

   Reports of daily use outside the laboratory.

• In production

  Neurazine feature: Brain-Computer Interfaces Enter the Clinic

  Issue 002.

Microelectrode arrays recording single-neuron and population activity in motor cortex; wireless telemetry; machine-learning decoders mapping activity to intention; emerging work on speech decoding and sensory feedback.

• Neuronal ensemble control of prosthetic devices by a human with tetraplegia, Nature (2006)
• High-performance brain-to-text communication via handwriting, Nature (2021)

1. 01How long do implanted arrays remain functional, and what limits their lifetime?
2. 02What are a participant's rights if the device's maker fails?
3. 03Who owns neural data, and what may be inferred from it?
4. 04Will non-invasive approaches ever approach implanted performance?

BCIs have crossed from academic demonstration into company-led human trials with regulatory oversight.

Durability data, speech decoding results, the first pivotal trials, and neural-data privacy legislation.